Mark L. Berch

Array ( [id] => 5620058 [patent_doc_number] => 20060189592 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-24 [patent_title] => 'Crystal of 1-methylcarbapenem compound' [patent_app_type] => utility [patent_app_number] => 11/352825 [patent_app_country] => US [patent_app_date] => 2006-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5357 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0189/20060189592.pdf [firstpage_image] =>[orig_patent_app_number] => 11352825 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5349960 [patent_doc_number] => 20090005321 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-01 [patent_title] => 'Phenylazetidinone Derivatives' [patent_app_type] => utility [patent_app_number] => 11/815775 [patent_app_country] => US [patent_app_date] => 2006-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 84580 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0005/20090005321.pdf [firstpage_image] =>[orig_patent_app_number] => 11815775 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5673002 [patent_doc_number] => 20060178357 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-10 [patent_title] => 'Chphalosporin-derived mercaptans as inhibitors of serine and metallo-beta-lactamases' [patent_app_type] => utility [patent_app_number] => 11/348066 [patent_app_country] => US [patent_app_date] => 2006-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 10686 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0178/20060178357.pdf [firstpage_image] =>[orig_patent_app_number] => 11348066 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4663058 [patent_doc_number] => 20080253965 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-16 [patent_title] => 'Small-Molecule Hsp90 Inhibitors' [patent_app_type] => utility [patent_app_number] => 11/814506 [patent_app_country] => US [patent_app_date] => 2006-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 14918 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0253/20080253965.pdf [firstpage_image] =>[orig_patent_app_number] => 11814506 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6520168 [patent_doc_number] => 20100261897 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-14 [patent_title] => 'Improved Process For the Preparation of Cephalosporin Antibiotic Intermediate' [patent_app_type] => utility [patent_app_number] => 11/794735 [patent_app_country] => US [patent_app_date] => 2006-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1472 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0261/20100261897.pdf [firstpage_image] =>[orig_patent_app_number] => 11794735 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 102710 [patent_doc_number] => 07723340 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-05-25 [patent_title] => 'Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith' [patent_app_type] => utility [patent_app_number] => 11/332617 [patent_app_country] => US [patent_app_date] => 2006-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33470 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/723/07723340.pdf [firstpage_image] =>[orig_patent_app_number] => 11332617 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7762520 [patent_doc_number] => 08114877 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-02-14 [patent_title] => 'Organic compounds' [patent_app_type] => utility [patent_app_number] => 11/722835 [patent_app_country] => US [patent_app_date] => 2006-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38897 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/114/08114877.pdf [firstpage_image] =>[orig_patent_app_number] => 11722835 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5650020 [patent_doc_number] => 20060135755 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-22 [patent_title] => 'Process for the synthesis of azetidinones' [patent_app_type] => utility [patent_app_number] => 11/305926 [patent_app_country] => US [patent_app_date] => 2005-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11445 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0135/20060135755.pdf [firstpage_image] =>[orig_patent_app_number] => 11305926 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5386542 [patent_doc_number] => 20090227787 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-10 [patent_title] => 'PROCESS FOR THE PREPARATION OF CEFIXIME' [patent_app_type] => utility [patent_app_number] => 11/722422 [patent_app_country] => US [patent_app_date] => 2005-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2459 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20090227787.pdf [firstpage_image] =>[orig_patent_app_number] => 11722422 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 296189 [patent_doc_number] => 07541460 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-06-02 [patent_title] => 'Process for preparing the antiviral agent [1S-(1alpha, 3alpha, 4beta)]-2-amino-1,9-dihydro-9-[4-hydroxy-3-(hydroxymethyl)-3-methylenecyclopentyl]-6H-purin-6-one' [patent_app_type] => utility [patent_app_number] => 11/311194 [patent_app_country] => US [patent_app_date] => 2005-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32643 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/541/07541460.pdf [firstpage_image] =>[orig_patent_app_number] => 11311194 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5808517 [patent_doc_number] => 20060094872 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-04 [patent_title] => 'Process for the preparation of cephalosporin antibiotic' [patent_app_type] => utility [patent_app_number] => 11/294410 [patent_app_country] => US [patent_app_date] => 2005-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2709 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0094/20060094872.pdf [firstpage_image] =>[orig_patent_app_number] => 11294410 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5754640 [patent_doc_number] => 20060223789 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-05 [patent_title] => 'Antibacterial substituted 7-acylamino-3-(methylhydrazono) methyl-cephalosporins and intermediates' [patent_app_type] => utility [patent_app_number] => 11/294066 [patent_app_country] => US [patent_app_date] => 2005-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15440 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0223/20060223789.pdf [firstpage_image] =>[orig_patent_app_number] => 11294066 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5596867 [patent_doc_number] => 20060160785 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-20 [patent_title] => 'Ezetimibe polymorphs' [patent_app_type] => utility [patent_app_number] => 11/295141 [patent_app_country] => US [patent_app_date] => 2005-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 9581 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20060160785.pdf [firstpage_image] =>[orig_patent_app_number] => 11295141 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5844414 [patent_doc_number] => 20060122165 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-08 [patent_title] => 'Crystalline cefdinir' [patent_app_type] => utility [patent_app_number] => 11/294116 [patent_app_country] => US [patent_app_date] => 2005-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6629 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20060122165.pdf [firstpage_image] =>[orig_patent_app_number] => 11294116 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 345243 [patent_doc_number] => 07498431 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-03-03 [patent_title] => 'Process for the preparation of chiral azetidinones' [patent_app_type] => utility [patent_app_number] => 11/291236 [patent_app_country] => US [patent_app_date] => 2005-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4453 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/498/07498431.pdf [firstpage_image] =>[orig_patent_app_number] => 11291236 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5716133 [patent_doc_number] => 20060079496 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-13 [patent_title] => 'Agglomerates by crystallisation' [patent_app_type] => utility [patent_app_number] => 11/290185 [patent_app_country] => US [patent_app_date] => 2005-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6329 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0079/20060079496.pdf [firstpage_image] =>[orig_patent_app_number] => 11290185 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5721319 [patent_doc_number] => 20060074095 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-06 [patent_title] => 'Novel purine derivatives, preparation method and use as medicines' [patent_app_type] => utility [patent_app_number] => 11/285870 [patent_app_country] => US [patent_app_date] => 2005-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17475 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0074/20060074095.pdf [firstpage_image] =>[orig_patent_app_number] => 11285870 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5721288 [patent_doc_number] => 20060074064 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-06 [patent_title] => 'Tricyclic 6-alkylidene-penems as beta-lactamase inhibitors' [patent_app_type] => utility [patent_app_number] => 11/283288 [patent_app_country] => US [patent_app_date] => 2005-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 77531 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0074/20060074064.pdf [firstpage_image] =>[orig_patent_app_number] => 11283288 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5626124 [patent_doc_number] => 20060264629 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-23 [patent_title] => 'Preparation of famciclovir and other purine derivatives' [patent_app_type] => utility [patent_app_number] => 11/270777 [patent_app_country] => US [patent_app_date] => 2005-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2551 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0264/20060264629.pdf [firstpage_image] =>[orig_patent_app_number] => 11270777 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5844958 [patent_doc_number] => 20060122391 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-08 [patent_title] => 'Nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases' [patent_app_type] => utility [patent_app_number] => 11/269819 [patent_app_country] => US [patent_app_date] => 2005-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33168 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20060122391.pdf [firstpage_image] =>[orig_patent_app_number] => 11269819 [rel_patent_id] =>[rel_patent_doc_number] =>)